Welcome to our dedicated page for Roth CH Acquisition Co. Warrant news (Ticker: USCTW), a resource for investors and traders seeking the latest updates and insights on Roth CH Acquisition Co. Warrant stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Roth CH Acquisition Co. Warrant's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Roth CH Acquisition Co. Warrant's position in the market.
TKB Critical Technologies 1 (Nasdaq: USCTU, USCT, USCTW) announced the extension of its business combination deadline to June 29, 2023, approved by 99% of shareholder votes. This extension allows TKB additional time to complete its merger with Wejo Group Limited. Shareholders redeemed a total of 17,533,296 shares, leaving approximately $55 million in TKB’s trust account, which is about 24% of the total pre-redemption balance. Co-CEO Angela Blatteis expressed gratitude for shareholder support, emphasizing plans to proceed with the merger.
TKB Critical Technologies 1 (Nasdaq: USCTU, USCT, USCTW) has announced it retained approximately $53 million in its trust account following the redemption deadline for Class A ordinary shares. The Extension Meeting aimed at shareholder approval for extending time to finalize a business combination has met its condition of maintaining at least 5.0 million Public Shares outstanding. TKB plans to reconvene the meeting on January 27, 2023, to allow shareholders to reverse redemptions. The business combination agreement with Wejo Group Limited is in progress.
TKB Critical Technologies 1 (Nasdaq: USCTU, USCT, USCTW) announced on January 24, 2023, that it has adjourned its extraordinary general meeting, scheduled for January 27, 2023, to seek shareholder approval for an extension to finalize its initial business combination with Wejo Group Limited. Shareholders can withdraw redemption requests until the vote, and those wishing to reverse their redemption must contact TKB's transfer agent. The firm focuses on investing in critical technologies, with leadership by Angela Blatteis and Greg Klein.
TKB Critical Technologies 1 has successfully closed its initial public offering (IPO) of 23 million units at $10.00 each, including 3 million units from the underwriters’ over-allotment option. The units, which consist of one Class A ordinary share and half a warrant, began trading on NASDAQ under symbol USCTU on October 27, 2021. The warrants can be exercised at $11.50 per share. The blank check company aims to find businesses in critical technologies aligned with U.S. national security and supply chain independence, focusing on various advanced sectors.